Genes for peripheral neuropathy and their relevance to clinical practice

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 10, 2004, Pages 1371-1372

  Donaghy, M ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; ASCORBIC ACID; CONNEXIN 32; EPITHELIAL GROWTH FACTOR RELATED PROTEIN 2; GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 1; I KAPPA B KINASE; MYELIN PROTEIN; MYOTUBULARIN RELATED PROTEIN 2; NUCLEIC ACID BINDING PROTEIN; PERIAXIN; PERIPHERAL MYELIN PROTEIN 22; PROTEIN; SERINE PALMITOYLTRANSFERASE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CHROMOSOME 17; CHROMOSOME DUPLICATION; CLINICAL PRACTICE; CONGENITAL HYPOMYELINATING NEUROPATHY; DISEASE CLASSIFICATION; DNA MODIFICATION; DYSAUTONOMIA; EDITORIAL; ELECTROPHYSIOLOGY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FAMILIAL AMYLOID POLYNEUROPATHY; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; LIPODYSTROPHY; MOLECULAR GENETICS; NEUROPATHY; ONCOGENE C MYB; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

BIOMEDICAL RESEARCH; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INHERITANCE PATTERNS; NEUROLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES; PROGNOSIS;

EID: 4644340813     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.041939     Document Type: Editorial

References (18)

1. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259-280.
2. Donaghy M, Hakin RN, Bomford JM, et al. Hereditary sensory neuropathy with neurotrophic keratitis. Description of an autosomal recessive disorder with a selective reduction of small myelinated nerve fibres and a discussion of the classification of the hereditary sensory neuropathies. Brain 1987;110:563-583.
3. Earl CJ, Fullerton PM, Wakefield GS, et al. Hereditary Neuropathy, with Liability to Pressure Palsies; a Clinical and Electrophysiological Study of Four Families. Q J Med 1964;33:481-498.
4. Glenner GG, Murphy MA. Amyloidosis of the nervous system. J Neurol Sci 1989;94:1-28.
5. Davis CJ, Bradley WG, Madrid R. The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum 1978;26:311-349.
6. Gabreels-Festen AA, Joosten EM, Gabreels FJ, et al. Hereditary motor and sensory neuropathy of neuronal type with onset in early childhood. Brain 1991;114:1855-1870.
7. Berciano J, Combarros O. Hereditary neuropathies. Curr Opin Neurol 2003;16:613-622.
8. Kuhlenbaumer G, Young P, Hunermund G, et al. Clinical features and molecular genetics of hereditary peripheral neuropathies. J Neurol 2000;249:1629-1650.
9. Pareyson D. Diagnosis of hereditary neuropathies in adult patients. J Neurol 2003;250:148-160.
10. Reilly MM, Hanna MG. Genetic neuromuscular disease. J Neurol Neurosurg Psychiatry 2002;73:II12-21.
11. Chaouch M, Allal Y, De Sandre-Giovannoli A, et al. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul Disord 2003;13:60-67.
12. Birouk N, Azzedine H, Dubourg O, et al. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. Arch Neurol 2003;60:598-604.
13. Donaghy M, Sisodiya SM, Kennett R, et al. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry 2000;69:799-805.
14. Pleasure DE. Genetics of Charcot-Marie-Tooth disease. Arch Neurol 2003;60:481-482.
15. Weatherall DJ. The new genetics and clinical practice. London: Nuffield Provincial Hospitals Trust, 1982.
16. Passage E, Norreel JC, Noack-Fraissignes P, et al. Ascorbic acid treatment corrects the phenotype of a model model of Charcot-Marie-Tooth disease. Nature Medicine 2004;10:396-401.
17. Sereda MW, Meyer zu Horst G, Suter U, et al. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nature Medicine 2003;9:1533-1537.
18. Department of Health. Our inheritance, our future. Realising the potential of genetics in the NHS. Genetics White Paper, 2003.